Oppenheimer & CO Inc Amarin Corp Plcuk Transaction History

Oppenheimer & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$1.07 - $1.34 $11,770 - $14,740	11,000 New	11,000 $13,000
Q1 2020 May 08, 2020	SELL	$4.0 - $21.53 $49,768 - $267,876	-12,442 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$13.94 - $24.12 $213,797 - $369,928	-15,337 Reduced 55.21%	12,442 $267,000
Q3 2019 Oct 31, 2019	BUY	$13.89 - $23.16 $63,477 - $105,841	4,570 Added 19.69%	27,779 $421,000
Q2 2019 Aug 09, 2019	BUY	$16.27 - $20.51 $377,610 - $476,016	23,209 New	23,209 $450,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.